Acelity L.P. Inc, Smith and Nephew and Molyncke Healthcare. Acelity L.P. Inc Dominating the Market for Global Advanced Wound Care Market in 2017

Global Advanced Wound Care Market is expected to reach USD 24,054.5 billion by 2025 and progressing at a significant CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Access Full Report:

The global advanced wound care market highly concentrated to a few big players and rest to local players who cater to domestic markets only. Advanced wound care market is dominated by Acelity Inc. accounting for a highest market share in 2017, followed by Smith And Nephew, Molnlycke Healthcare and among others.

Acelity L.P. Inc:

Acelity L.P Inc was founded in 1976 and headquartered in Texas, United States. The company is involved in wound management, open abdomen management and incision management, epidermal harvesting, and animal health. The company is mainly focused on surgical healing and hospital patient-mobility equipment, including a tissue-repair therapy in hospitals across the worldwide. Acelity is formed by three organization KCI, Systagenix and LifeCell.

The compnay has it’s subsidiaries namely Plexus Enterprises, Inc (U.S.), SystagenixWound Management Mezz B.V. (Netherland), Technimotion, LLC (U.S.), The Kinetic Concepts Foundation (U.S.), Equi-Tron Manufacturing, Inc (Canada).

Acelity L.P. Inc is serving in more than 90 Countries.  


Founded in 1937 and headquartered in London, U.K. Smith And Nephew. is involved in designing., developing and selling of medical devices. The company operates in different segments namely Knee Implants, Advanced Wound Care, Sports Medicine Joint Repair, Arthroscopic Enabling Technologies, Hip Implants, Trauma & Extremities, Advanced Wound Bioactives, Advanced Wound Devices and Other Surgical Businesses. The advanced wound care market related products and services lie under advanced wound care business segment.

The company has its subsidiaries namely Blue Belt Technologies UK Limited (U.K.), Neotherix Limited (U.S.), Plus Orthopedics (U.K.) Limited (U.K.), Arthrocare Corporation (U.S.), Bioventus LLC (U.S.), Smith & Nephew Pty Limited (Australia), ArthoCareMedical Devices (Beijing) Co.Limited (China),.

The company has its global presence in many regions America, Europe, Asia, Australasia, Middle East and Africa.


Abbott was incorporated in 1849 and headquartered in Gothenburg, Sweden. The company is involved in developing and providing single-use surgical and wound care products to customers, healthcare professionals, and patients internationally. The company offers the products and solution offers through wound management prevent pressure ulcers, surgical solutions. Advanced wound care is offered under wound management.

The company has its subisdiaries namely Molnlycke Health Care Inc., Wytwórnia Artykulów Higienicznych JKT Sp. z o.o., Molnlycke Health Care US, LLC, Molnlycke Health Care (Thailand) Ltd., Rynel, Inc. and others .

Molnlycke Healthcare operates in Company has global presence across the world including Australia, Austria, U.S., Switzerland, Sweden, Singapore, Hungary, Italy, Russia and among others.